Rosemarie Roeloffs
Research Triangle Park Foundation(US)Pfizer (United States)(US)
Publications by Year
Research Areas
Ion channel regulation and function, Neuroscience and Neuropharmacology Research, Pain Mechanisms and Treatments, Cardiac electrophysiology and arrhythmias, Dermatology and Skin Diseases
Most-Cited Works
- → A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat(2007)520 cited
- → N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide (ICA-27243): A Novel, Selective KCNQ2/Q3 Potassium Channel Activator(2007)115 cited
- → A novel selective and orally bioavailable N a v 1.8 channel blocker, PF ‐01247324, attenuates nociception and sensory neuron excitability(2015)97 cited
- → Discovery and Biological Evaluation of 5-Aryl-2-furfuramides, Potent and Selective Blockers of the Nav1.8 Sodium Channel with Efficacy in Models of Neuropathic and Inflammatory Pain(2008)84 cited
- → In Vivo Profile of ICA-27243 [N-(6-Chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a Potent and Selective KCNQ2/Q3 (Kv7.2/Kv7.3) Activator in Rodent Anticonvulsant Models(2008)65 cited
- → Novel KCNQ2/Q3 Agonists as Potential Therapeutics for Epilepsy and Neuropathic Pain(2009)46 cited
- → N-Pyridyl and Pyrimidine Benzamides as KCNQ2/Q3 Potassium Channel Openers for the Treatment of Epilepsy(2011)45 cited
- → KCNQ potassium channels: drug targets for the treatment of epilepsy and pain(2004)41 cited
- → Dispersal and Population-Genetic Structure of the Cooperative Spider, Agelena consociata, in West African Rainforest(1988)37 cited
- → Design and identification of a novel, functionally subtype selective GABAApositive allosteric modulator (PF-06372865).(2019)32 cited